Novartis and Incyte to trial Jakavi for Covid-19
Novartis, in alliance with Incyte, has announced plans to assess Jakavi (ruxolitinib) in a Phase...
Novartis, in alliance with Incyte, has announced plans to assess Jakavi (ruxolitinib) in a Phase...
Vertex Pharmaceutics has announced it has entered into a definitive agreement to acquire Semma Therapeutics...
Third Rock Ventures has launched Maze Therapeutics, a start-up focused on translating genetic insights into new medicines.
US-based conglomerate General Electric (GE) has entered into a definitive agreement to divest its Biopharma...
A new report by Cancer Research UK has concluded that a new drug payment system,...
The US Food and Drug Administration (FDA) has accepted a new drug application (NDA) submitted...
The Association of the British Pharmaceutical Industry (ABPI), a trade group representing drugmakers in the...
Japan-based Taiho Pharmaceutical has signed an agreement to licence its epidermal growth factor receptor (EGFR)...
US Department of Health & Human Services (HHS) has proposed a new rule to end...
The UK Government has set out a plan to fight antimicrobial resistance (AMR) in the...